Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein

Overview of attention for article published in Frontiers in Nuclear Medicine, November 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,332 followers.

@zorromdgr @_arachthos Είναι θέμα χρόνου πάντως να βγει κι ο πρώτος PET ιχνηθέτης ώστε να μην χρειάζονται βιοψίες https://t.co/HxQSLl2TFE

RT @FrontNuclearMed: New Research: Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein https://t.co/…

RT @FrontNuclearMed: New Research: Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein https://t.co/…

RT @FrontNuclearMed: New Research: Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein https://t.co/…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.